QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2014    内容类型：期刊论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro 期刊论文 ACTA PHARMACOLOGICA SINICA, 2014, 卷号: 35, 期号: 3, 页码: 401-409 作者:  Wu, Li-xian;  Wu, Ying;  Chen, Rui-jia;  Liu, Yang;  Huang, Li-sen 收藏  |  浏览/下载：20/0  |  提交时间：2019/01/08 chronic myelogenous leukemia  imatinib resistance  Bcr-Abl  mutantion  curcumin  C817  leukemia stem cell   Targeting the MYC and PI3K Pathways Eliminates Leukemia-Initiating Cells in T-cell Acute Lymphoblastic Leukemia 期刊论文 cancer research, 2014 Schubbert, Suzanne; Cardenas, Anjelica; Chen, Harrison; Garcia, Consuelo; Guo, Wei; Bradner, James; Wu, Hong 收藏  |  浏览/下载：6/0  |  提交时间：2015/11/13 CANCER STEM-CELLS  GAMMA-SECRETASE INHIBITORS  BET BROMODOMAIN INHIBITION  ACUTE MYELOID-LEUKEMIA  AURORA KINASES  C-MYC  PTEN  NOTCH1  MUTATIONS  GROWTH   Study on the treatment of the p15 gene combined with Bcr-abl-specific siRNA and STI571 for chronic myeloid leukemia 期刊论文 http://dx.doi.org/10.4238/2014.May.30.4, 2014 Wang, W.; Du, Y.; Li, N. -N.; Lv, F. -F.; Lin, G. -Q.; 王玮 收藏  |  浏览/下载：6/0  |  提交时间：2015/07/22 CHRONIC MYELOGENOUS LEUKEMIA  RNA INTERFERENCE  P16(INK4A)  IMATINIB  METHYLATION  P15(INK4B)  MUTATIONS  CELLS  CML   SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells 期刊论文 CANCER BIOLOGY & THERAPY, 2014, 卷号: 15, 期号: 7, 页码: 951-962 Bu, Qiangui; Cui, Lijing; Li, Juan; Du, Xin; Zou, Waiyi; Ding, Ke; Pan, Jingxuan 收藏  |  浏览/下载：19/0  |  提交时间：2016/12/16 SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells 期刊论文 CANCER BIOLOGY & THERAPY, 2014, 卷号: 15, 期号: 7, 页码: 951-962 作者:  Cui, Lijing;  Du, Xin;  Zou, Waiyi;  Ding, Ke;  Pan, Jingxuan 收藏  |  浏览/下载：11/0  |  提交时间：2018/12/13 Rapamycin combined with celecoxib enhanced antitumor effects of mono treatment on chronic myelogenous leukemia cells through downregulating mTOR pathway. 期刊论文 Tumour Biology, 2014, 卷号: Vol.35 No.7, 页码: 6467-6474 作者:  Jie Li;  Liying Xue;  Hongling Hao;  Ruoyu Li;  Jianmin Luo 收藏  |  浏览/下载：2/0  |  提交时间：2019/03/26 Chronic  myelogenous  leukemia  mTOR  Rapamycin  Celecoxib